Abstract
Within 24 h of bland embolization of carcinoid liver metastasis, patient developed flushing and severe hypotension consistent with carcinoid crisis. Octreotide pre- and post-procedure remains the mainstay for prevention and treatment of carcinoid crisis.
MeSH terms
-
Aged
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Embolization, Therapeutic / adverse effects*
-
Humans
-
Liver Neoplasms* / complications
-
Liver Neoplasms* / pathology
-
Liver Neoplasms* / therapy
-
Male
-
Malignant Carcinoid Syndrome* / etiology
-
Malignant Carcinoid Syndrome* / physiopathology
-
Malignant Carcinoid Syndrome* / therapy
-
Neoplasm Metastasis
-
Octreotide / therapeutic use
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Hormonal
-
Octreotide